CRISPR Therapeutics AG Market Cap

CRISPR Therapeutics AG has a market cap or net worth of 2.44 billion as of April 28, 2025. Its market cap has decreased by -42.74% in one year.

Market Cap

2.44B

Enterprise Value

1.19B

Revenue

29.81M

Ranking

n/a

PE Ratio

n/a

Stock Price

37.69

Market Cap Chart

Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from 451.35M to 2.44B, an increase of 441.37%. That is a compound annual growth rate of 21.90%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2025	2.44B	-8.94%
Dec 31, 2024	2.68B	-31.26%
Dec 29, 2023	3.90B	47.79%
Dec 30, 2022	2.64B	-38.32%
Dec 31, 2021	4.28B	-45.95%
Dec 31, 2020	7.92B	189.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	161.27B
Shell	148.36B
HSBC Holdings	146.33B
Unilever	116.92B
Rio Tinto Group	77.50B
RELX PLC	73.73B
British American Tobacco p.l.c.	68.91B
Rolls-Royce Holdings	63.23B

Market Cap Rankings